Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Response to Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05559476
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,029
Post-approval studies (Phase 4)Study completedNCT00993668
What this trial is testing

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 224
Not applicableStudy completedNCT03930017
What this trial is testing

Pregnancy, Arsenic and Immune Response

Who this might be right for
Arsenic--ToxicologyImmunologic Disorders Complicating PregnancyVaccine Response Impaired+2 more
Johns Hopkins Bloomberg School of Public Health 784
Not applicableStudy completedNCT01707628
What this trial is testing

Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab

Who this might be right for
Non-Hodgkin Lymphoma (NHL)
St. Antonius Hospital 98
Early research (Phase 1)Study completedNCT01368029
What this trial is testing

Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine

Who this might be right for
HealthyElderly
Massachusetts General Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01561768
What this trial is testing

Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults

Who this might be right for
Influenza
Novavax 500
Testing effectiveness (Phase 2)Study completedNCT05823974
What this trial is testing

Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,275
Post-approval studies (Phase 4)Looking for participantsNCT06841913
What this trial is testing

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Who this might be right for
Smoke ExposureInfluenza
University of North Carolina, Chapel Hill 112
Post-approval studies (Phase 4)Study completedNCT02655874
What this trial is testing

Tropical Influenza Control Strategies for the Elderly

Who this might be right for
Influenza, Human
Tan Tock Seng Hospital 200
Post-approval studies (Phase 4)Study completedNCT03020537
What this trial is testing

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

Who this might be right for
Influenza
Stanford University 8
Post-approval studies (Phase 4)Study completedNCT00649922
What this trial is testing

Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abbott 226
Not applicableStudy completedNCT05690373
What this trial is testing

Probiotics and Influenza Vaccination Response

Who this might be right for
Vaccine Response
The Archer-Daniels-Midland Company 100
Not applicableStudy completedNCT04794829
What this trial is testing

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

Who this might be right for
InfluenzaCOVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT01359150
What this trial is testing

Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo

Who this might be right for
Rheumatoid Arthritis
Pfizer 223
Post-approval studies (Phase 4)Study completedNCT03022396
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

Who this might be right for
Influenza
Stanford University 82
Testing effectiveness (Phase 2)Study completedNCT01682369
What this trial is testing

ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses

Who this might be right for
Influenza
University of Oxford 90
Testing effectiveness (Phase 2)WithdrawnNCT00989274
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Who this might be right for
Influenza
Instituto Nacional de Salud Publica, Mexico
Not applicableUnknownNCT01084434
What this trial is testing

Probiotic, Prebiotic and Synbiotic Effect on Immunity

Who this might be right for
Dietary Intervention
University of Reading 100
Early research (Phase 1)Study completedNCT01545349
What this trial is testing

Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine

Who this might be right for
HealthyInfluenza
Patricia L. Hibberd 30
Testing effectiveness (Phase 2)WithdrawnNCT01008956
What this trial is testing

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

Who this might be right for
Influenza
GlaxoSmithKline
Next Page